Yayın:
Efficacy and tolerability of first-line chemotherapy in elderly patients (age ≥70 years) with metastatic gastric cancer: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)

dc.contributor.authorTurhal, Serdar
dc.contributor.authorMehmet Türkeli
dc.contributor.authorMuhammet Bekir Hacıoğlu
dc.contributor.authorAbdullah Sakin
dc.contributor.authorEmel Yaman
dc.contributor.authorEzgi Çoban
dc.contributor.authorDoğan Koca
dc.contributor.authorMustafa Karaca
dc.contributor.authorMelih Şimşek
dc.contributor.authorAykut Bahçeci
dc.contributor.authorE. Sen
dc.contributor.authorTülay Eren
dc.contributor.authorB.ö Aliustaoglu
dc.contributor.authorTeoman Şakalar
dc.contributor.authorNurhan Önal Kalkan
dc.contributor.authorGökmen Aktaş
dc.contributor.authorMehmet Bilici
dc.contributor.authorSerdar Turhal
dc.contributor.authorMustafa Beneklı
dc.contributor.authorSalim Başol Tekin
dc.contributor.orcid0000-0002-7931-9078
dc.contributor.orcid0000-0001-8490-3239
dc.contributor.orcid0000-0003-2538-8569
dc.contributor.orcid0009-0007-7911-1799
dc.contributor.orcid0000-0002-6513-0768
dc.contributor.orcid0000-0002-3954-5273
dc.contributor.orcid0000-0003-0633-8558
dc.contributor.orcid0000-0001-7921-5204
dc.contributor.orcid0000-0002-0088-1149
dc.contributor.orcid0000-0003-2749-9414
dc.contributor.orcid0000-0002-2823-332X
dc.contributor.orcid0000-0003-4199-6943
dc.contributor.orcid0000-0003-1306-2238
dc.contributor.orcid0000-0003-3184-4946
dc.contributor.orcid0000-0002-0974-3412
dc.date.accessioned2025-11-13T22:21:33Z
dc.date.issued2016-10-01
dc.identifier.doihttps://doi.org/10.1093/annonc/mdw371.42
dc.identifier.endpagevi220
dc.identifier.issn0923-7534
dc.identifier.openalexW2586835911
dc.identifier.startpagevi220
dc.identifier.urihttps://hdl.handle.net/11421/13919
dc.identifier.urihttps://doi.org/10.1093/annonc/mdw371.42
dc.identifier.volume27
dc.language.isoen
dc.relation.ispartofAnnals of Oncology
dc.rightsrestrictedAccess
dc.subjectMedicine
dc.subjectTolerability
dc.subjectNeutropenia
dc.subjectInternal medicine
dc.subjectChemotherapy
dc.subjectCancer
dc.subjectPerformance status
dc.subjectChemotherapy regimen
dc.subjectGastroenterology
dc.subjectSurgery
dc.subjectOncology
dc.subjectAdverse effect
dc.subject.sdg3
dc.titleEfficacy and tolerability of first-line chemotherapy in elderly patients (age ≥70 years) with metastatic gastric cancer: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5108484042

Dosyalar

Koleksiyonlar